Biocon Ltd

Common Name
Biocon
Country
India
Sector
Healthcare
Industry
Biotechnology
Employees
16,315
Ticker
BIOCON
Exchange
NATIONAL STOCK EXCHANGE OF INDIA
Description
Biocon Ltd. is a prominent biopharmaceutical company based in India, specializing in the development and production of innovative and cost-effective medical therapies. The company's primary focus lies...

Biocon's Financial Statements Preview

Below are the financial statements of Biocon, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in billions of INR
2025 as of 2025-03-31
2024 as of 2024-03-31
Assets
Non-current assets
Property, plant and equipment
87.08a
74.18a
Capital work-in-progress
41.02a
39.85a
Right-of-use assets
6.04a
5.75a
Goodwill
167.86a
163.72a
Other intangible assets
58.65a
62.79a
Intangible assets under development
44.07a
40.08a
Financial assets
Investments
6.8a
6.84a
Derivative assets
1.87a
2.66a
Other financial assets
0.68a
1.47a
Deferred tax assets (net)
2.58a
3.17a
Income-tax assets (net)
3.71a
4.13a
Other non-current assets
4.76a
4.28a
Total non-current assets
425.11a
408.92a
Current assets
Inventories
49.31a
49.44a
Financial assets
Investments
4.47a
3.16a
Trade receivables
54.88a
62.31a
Cash and cash equivalents
32.27a
12.34a
Bank balances other than (iii) above
8.93a
10.25a
Derivative assets
0.96a
1.38a
Other financial assets
4.56a
5.77a
Other current assets
7.47a
7.15a
Total current assets
162.86a
151.79a
Total assets
587.97a
560.71a
Equity
Equity share capital
6a
6a
Other equity
210.44a
191.83a
Equity attributable to owners of the company
216.44a
197.84a
Non-controlling interests
60.69a
54.91a
Total equity
277.13a
252.75a
Liabilities
Non-current liabilities
Financial liabilities
Borrowings
124.05a
129.32a
Lease liabilities
5.39a
4.92a
Derivative liabilities
0.23a
0a
Other financial liabilities
28.28a
10.73a
Provisions
2.61a
2.38a
Deferred tax liabilities (net)
3.58a
3.92a
Other non-current liabilities
3.37a
3.11a
Total non-current liabilities
167.51a
154.37a
Current liabilities
Financial liabilities
Borrowings
53.5a
27.97a
Lease liabilities
0.67a
0.55a
Trade payables
Total outstanding dues of micro enterprises and small enterprises
1.32a
0.96a
Total outstanding dues of creditors other than micro enterprises and small enterprises
64.17a
61.76a
Derivative liabilities
0.46a
0.01a
Other financial liabilities
9.33a
50.01a
Other current liabilities
10.25a
7.77a
Provisions
1.92a
1.8a
Current tax liabilities (net)
1.73a
2.77a
Total current liabilities
143.34a
153.59a
Total liabilities
310.85a
307.96a
Total equity and liabilities
587.97a
560.71a
Download Data

Verified Sources Behind Biocon’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Biocon’s data sources below and access millions more through our Disclosure Search.

a. Biocon's Integrated Report 2025
a. Biocon's Integrated Report 2025
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?